Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
28.40
+0.91 (3.31%)
Nov 2, 2026, 1:25 PM CST
SHA:603882 Market Cap
SHA:603882 has a market cap or net worth of 12.97 billion as of October 30, 2026. It is the 6,706th most valuable company in the world and the 1,202nd biggest in China. Its market cap has decreased by 6.37% in one year.
Market Cap
12.97B
Enterprise Value
11.57B
Revenue
5.89B
Global Rank
Country Rank
#1,202 China
PE Ratio
46.96
ChartMarket Cap Chart
Since September 8, 2017, SHA:603882's market cap has increased from 4.57B to 12.97B, an increase of 183.80%. That is a compound annual growth rate of 12.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 12.97B | -1.29% |
| Dec 31, 2025 | 13.14B | 3.91% |
| Dec 31, 2024 | 12.64B | -56.89% |
| Dec 29, 2023 | 29.33B | -19.71% |
| Dec 30, 2022 | 36.53B | -29.55% |
| Dec 31, 2021 | 51.85B | -11.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Tigermed Consulting | 39.28B |
| Joinn Laboratories(China)Co.,Ltd. | 30.32B |
| BGI Genomics | 14.17B |
| Dian Diagnostics Group | 12.36B |
| Beijing Strong Biotechnologies,Inc. | 7.29B |
| Amoy Diagnostics | 7.27B |
| Shanghai Runda Medical Technology | 5.54B |
| Maccura Biotechnology Co.Ltd | 5.43B |